Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Pediatr Surg Int ; 34(1): 75-78, 2018 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-29052000

RESUMO

OBJECTIVES: This study reviews the results of our previously described modification of the minimally invasive (Nuss) procedure for correction of pectus excavatum. It utilizes a subxyphoid incision with central fixation to maximize safe bar passage and minimize bar displacement. METHODS: Consecutive patients corrected with the modified Nuss procedure between 2010 and 2015 form the basis of this study. RESULTS: During the study period, 73 patients had correction of their pectus excavatum by the modified Nuss procedure, utilizing subxyphoid incision and central fixation. Average age was 14.3 (range 8-19). 54 patients were male, 19 female. The average Haller index was 4.3 (range 3.2-7.2). No episodes of cardiac perforation, hemothorax or significant pneumothorax were recorded. Bar displacement occurred in two patients (2.7%) with one late recurrence after bar removal. CONCLUSIONS: Our modification of the Nuss procedure is effective at preventing intrathoracic complications and cardiac perforation. Central fixation had a lower rate of bar displacement compared to published reports. Additional efforts are needed to further reduce bar displacement.


Assuntos
Tórax em Funil/cirurgia , Procedimentos Cirúrgicos Minimamente Invasivos/métodos , Adolescente , Criança , Feminino , Humanos , Complicações Intraoperatórias/prevenção & controle , Masculino , Procedimentos Cirúrgicos Minimamente Invasivos/instrumentação , Complicações Pós-Operatórias/prevenção & controle , Adulto Jovem
2.
Ann Vasc Dis ; 10(4): 438-440, 2017 Dec 25.
Artigo em Inglês | MEDLINE | ID: mdl-29515711

RESUMO

Symptomatic penetration of the retroperitoneal structures by inferior vena cava (IVC) filter is a rare clinical entity. Vast majority of these patients require laparotomy and open retrieval of the filter. We report a case of a filter penetrating into the duodenum within two months of implantation resulting in gastrointestinal bleeding. The patient was successfully managed with percutaneous retrieval of the filter, blood transfusion and serial abdominal examination thus avoiding laparotomy.

3.
Obstet Gynecol ; 125(1): 197-203, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-25560125

RESUMO

OBJECTIVE: To report outcomes associated with the administration of granulocyte colony-stimulating factor (G-CSF) to women with chronic neutropenia during pregnancy. METHODS: We conducted an observational study of women of childbearing potential with congenital, cyclic, idiopathic, or autoimmune neutropenia enrolled in the Severe Chronic Neutropenia International Registry to determine outcomes of pregnancies, without and with chronic G-CSF therapy, 1999-2014. Treatment decisions were made by the patients' personal physicians. A research nurse conducted telephone interviews of all enrolled U.S. women of childbearing potential using a standard questionnaire. Comparisons used Fisher's exact test analysis and Student's t test. RESULTS: One hundred seven women reported 224 pregnancies, 124 without G-CSF therapy and 100 on chronic G-CSF therapy (median dose 1.0 micrograms/kg per day, range 0.02-8.6 micrograms/kg per day). There were no significant differences in adverse events between the groups considering all pregnancies or individual mothers, for example, spontaneous terminations (all pregnancies: no G-CSF in 27/124, G-CSF in 13/100; P=.11, Fisher's exact test), preterm labors (all pregnancies, no G-CSF in 9/124, G-CSF in 2/100, P=.12). A study with at least 300 per group would be needed to detect a difference in these events with 80% statistical power (α=0.05). Four newborns of mothers with idiopathic or autoimmune neutropenia not on G-CSF (4/101) had life-threatening infections, whereas there were no similar events (0/90) in the treated group, but this difference was also not statistically significant (P=.124). Adverse events in the neonates were similar for the two groups. CONCLUSION: This observational study showed no significant adverse effects of administration of G-CSF to women with severe chronic neutropenia during pregnancy. LEVEL OF EVIDENCE: III.


Assuntos
Fator Estimulador de Colônias de Granulócitos/uso terapêutico , Neutropenia/tratamento farmacológico , Neutrófilos , Complicações Hematológicas na Gravidez/tratamento farmacológico , Aborto Espontâneo/epidemiologia , Adolescente , Adulto , Feminino , Idade Gestacional , Humanos , Recém-Nascido , Infecções/epidemiologia , Contagem de Leucócitos , Nascido Vivo , Neutropenia/sangue , Trabalho de Parto Prematuro/epidemiologia , Gravidez , Complicações Hematológicas na Gravidez/sangue , Adulto Jovem
4.
J Pediatr Hematol Oncol ; 35(2): e64-6, 2013 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-23211693

RESUMO

Management of an 8-year-old boy with Hodgkin lymphoma is presented. The patient had several recurrences of neutropenic enterocolitis and eventually required ileocecectomy. A review of the literature on this difficult problem affecting pediatric oncology patients is presented.


Assuntos
Enterocolite Neutropênica/terapia , Criança , Enterocolite Neutropênica/patologia , Fator Estimulador de Colônias de Granulócitos/uso terapêutico , Humanos , Masculino , Nutrição Parenteral Total , Recidiva , Tomografia Computadorizada por Raios X
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...